RESEARCH TRIANGLE PARK, N.C. - Oct. 2, 1996 - MiniDoc AB and Quintiles, Inc., The U.S. division of one of the largest contract research organizations (CRO) in the world, have signed a global sales and marketing agreement. The agreement covers all of MiniDoc's services and products in the field of data collection in clinical research.
The agreement allows Quintiles to offer clients more competitive solutions based on MiniDoc's technology to capture and process patient data, and gives MiniDoc immediate access to Quintiles' global sales and marketing organization. MiniDoc is an international company specializing in fully integrated computerized systems for data collection designed to reduce or eliminate paperwork in clinical trials.
One example of MiniDoc's advanced technology is a hand-held device that clinical trial patients can use to directly input information needed to determine a drug's safety and effectiveness. The device also can remind patients about drug-dosing and data-entry schedules. Data from the device can be downloaded for study and analysis, reducing paperwork and increasing accuracy and speed.
MiniDoc, headquartered in Uppsala, Sweden, operates subsidiaries in the United States, United Kingdom, and Germany. Its business concept is "to provide the pharmaceutical industry with services and products that contribute to quality and speed in the process of patient data capture in clinical research."
MiniDoc has 57 employees, 43 of whom are based outside of Sweden, and operates in the U.S. through its subsidiary MiniDoc, Inc., headquartered in Cary, N.C. MiniDoc is listed on the Stockholm Borsinformations exchange.
The parent company of Quintiles, Inc., Quintiles Transnational Corp., with headquarters near Research Triangle Park, North Carolina, has almost 3,000 employees and operates in 19 countries. Quintiles is quoted on the Nasdaq stock exchange (Nasdaq-QTRN) and had a revenue of $156 million in 1995.